SEARCH

MEDIA PACK

NEWS

Current Edition

Bristol Myers

Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028

As a top-selling drug worldwide, Pfizer and Bristol Myers Squibb’s Eliquis is a major target for generic players looking to steal branded sales. But with …

8 September 2021 Regional News Bristol Myers Eliquis

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

SEARCH

MENU

Current Edition

Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028

Journal for Clinical Studies